Cargando…
Effects of treatment modalities for Graves’ hyperthyroidism on Graves’ orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement
Autores principales: | Bartalena, L., Macchia, P. E., Marcocci, C., Salvi, M., Vermiglio, F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374116/ https://www.ncbi.nlm.nih.gov/pubmed/25722226 http://dx.doi.org/10.1007/s40618-015-0257-z |
Ejemplares similares
-
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
por: Perros, P., et al.
Publicado: (2017) -
Management of Graves’ hyperthyroidism and orbitopathy in time of COVID-19 pandemic
por: Bartalena, L., et al.
Publicado: (2020) -
Unmet therapeutic, educational and scientific needs in parathyroid disorders: Consensus Statement from the first European Society of Endocrinology Workshop (PARAT)
por: Bollerslev, Jens, et al.
Publicado: (2019) -
Enhanced recovery after bariatric surgery: an Italian consensus statement
por: Marinari, Giuseppe, et al.
Publicado: (2022) -
2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs
por: Podell, M., et al.
Publicado: (2016)